These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 3052955

  • 1. Detection of novel beta 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition.
    Ogawa H, Saito A, Oda O, Nakajima M, Chung TG.
    Clin Nephrol; 1988 Sep; 30(3):158-63. PubMed ID: 3052955
    [Abstract] [Full Text] [Related]

  • 2. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
    Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T.
    J Clin Invest; 1993 Sep; 92(3):1243-52. PubMed ID: 8376584
    [Abstract] [Full Text] [Related]

  • 3. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT, Williams AW, Johnson WJ.
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [Abstract] [Full Text] [Related]

  • 4. [Amyloidosis associated with chronic hemodialysis. The prognostic significance of beta 2-microglobulin changes in patients with terminal chronic kidney failure treated by repeated hemodialysis].
    Manasia M, Meseşan M, Gherman-Căprioară M, Malide D, Paţiu IM, Pârvu L, Vlăduţiu D, Spânu CS.
    Med Interna; 1991 Apr; 43(1-2):129-34. PubMed ID: 1670118
    [Abstract] [Full Text] [Related]

  • 5. Amyloid deposition in systemic organs in long-term hemodialysis patients.
    Ogawa H, Saito A, Hirabayashi N, Hara K.
    Clin Nephrol; 1987 Oct; 28(4):199-204. PubMed ID: 3319310
    [Abstract] [Full Text] [Related]

  • 6. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A, Gejyo F.
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [Abstract] [Full Text] [Related]

  • 7. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
    Baldrati L, Baldrati L, Delvecchio C, Capponcini C, Docci D, Turci F, Feletti C.
    Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
    [Abstract] [Full Text] [Related]

  • 8. [Amyloid deposits in hemodialysis patients: immunochemical analysis].
    Argiles A, Mourad G, Axelrud-Cavadore C, Cavadore JC, Mion C.
    Nephrologie; 1987 Sep; 8(2):51-4. PubMed ID: 3302740
    [Abstract] [Full Text] [Related]

  • 9. Beta-2-microglobulin-associated amyloidosis in chronic hemodialysis patients with carpal tunnel syndrome.
    Ullian ME, Hammond WS, Alfrey AC, Schultz A, Molitoris BA.
    Medicine (Baltimore); 1989 Mar; 68(2):107-15. PubMed ID: 2646507
    [Abstract] [Full Text] [Related]

  • 10. Detection of electrophoretic heterogeneity of serum beta 2-microglobulin in chronic renal failure.
    Ogawa H, Saito A, Oda O, Nakajima M, Chung TG.
    ASAIO Trans; 1988 Mar; 34(3):196-9. PubMed ID: 3058173
    [Abstract] [Full Text] [Related]

  • 11. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W, Szepietowski T.
    Postepy Hig Med Dosw; 1992 Mar; 46(2):209-38. PubMed ID: 1470582
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis.
    Gejyo F, Homma N, Suzuki Y, Arakawa M.
    N Engl J Med; 1986 Feb 27; 314(9):585-6. PubMed ID: 3080684
    [No Abstract] [Full Text] [Related]

  • 13. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
    Prinseau J, Baglin A, Benoit J, Leparc JM, Got C, Louis MF, Attar B, Fritel D.
    Ann Med Interne (Paris); 1989 Feb 27; 140(2):94-8. PubMed ID: 2662855
    [Abstract] [Full Text] [Related]

  • 14. Haemodialysis-associated beta 2M amyloidosis: current controversies.
    Stein G, Sperschneider H, Fünfstück R, Ritz E.
    Nephrol Dial Transplant; 1994 Feb 27; 9 Suppl 3():48-50. PubMed ID: 8072726
    [Abstract] [Full Text] [Related]

  • 15. [Dialysis amyloidosis and beta-2-microglobulin].
    Sulková S, Votruba T.
    Cas Lek Cesk; 1989 Jan 13; 128(3):68-73. PubMed ID: 2655913
    [Abstract] [Full Text] [Related]

  • 16. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin.
    Shirahama T, Skinner M, Cohen AS, Gejyo F, Arakawa M, Suzuki M, Hirasawa Y.
    Lab Invest; 1985 Dec 13; 53(6):705-9. PubMed ID: 2415776
    [Abstract] [Full Text] [Related]

  • 17. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F, Homma N, Arakawa M.
    Kidney Int Suppl; 1993 Jun 13; 41():S78-82. PubMed ID: 8320951
    [Abstract] [Full Text] [Related]

  • 18. [Carpal tunnel syndrome associated with long-term hemodialysis: case report].
    Suwa H, Hanakita J, Sakaida H, Nishi S, Ohta F, Mori N, Nagamine T, Taniyama K.
    No Shinkei Geka; 1989 Aug 13; 17(8):747-50. PubMed ID: 2685635
    [Abstract] [Full Text] [Related]

  • 19. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
    Kes P, Zubcić A, Ratković-Gusić I, Prsa M, Sefer S.
    Acta Med Croatica; 1997 Aug 13; 51(2):105-9. PubMed ID: 9204596
    [Abstract] [Full Text] [Related]

  • 20. [AA, AL and A beta 2M amyloidoses as seen by the rheumatologist].
    Gerster JC.
    Rev Med Suisse Romande; 2000 Oct 13; 120(10):765-9. PubMed ID: 11109904
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.